A new study identifies two ways in which APOBEC3A— a vital enzyme that is responsible for genetic changes resulting in a variety of cancers while protecting our cells against viral infection—is controlled.
The enzyme APOBEC3A is a vital part of the innate immune system that works to protect cells from viral infection by inducing mutations to block viruses from replicating. However, APOBEC3A also induces mutations by directly attacking the genome of cancer cells, which results in increased levels of DNA mutations that lead to cancer progression, metastasis and drug resistance.
“In our previous studies, we demonstrated that APOBEC3A-induced DNA mutations are very frequent in cancer patients. In fact, we found they are present in up to 80 percent of certain cancer types such as lung, breast or bladder cancers,” said the senior author.
In this study, the authors characterized how both viral infection and genotoxic stress caused by chemotherapeutic drugs transiently up-regulate APOBEC3A. Their work illustrates how viral infection triggers a specific innate immune response to activate APOBEC3A expression in human cells and how it is an important step in the elimination of the virus. Their work also illustrates how different chemotherapeutic drugs stimulate APOBEC3A, but through a completely different type of immune response which, this time, causes mutations that further enhance cancer aggressivity.
“Together, our results reveal different ways for the cells to regulate APOBEC3A expression to address different types of stresses that the cell may encounter,” said the author. “By understanding how cancer cells and viral infections regulate APOBEC3A expression, we are poised to take critical step forward toward the development of both new therapeutic strategies to fight cancer and new anti-viral therapies.”
More work is needed to develop strategies to prevent the formation of DNA mutations caused by APOBEC3A in the cancer genome that increase tumor heterogeneity, promoting disease progression and resistance to therapies. With regard to viral infections, the next step is to determine whether certain types of mutations previously detected in viruses such as SARS-CoV-2 (COVID-19) are the result of APOBEC3A activity and affect the replication of the virus in the cells.
https://www.nature.com/articles/s41467-021-25203-4
http://sciencemission.com/site/index.php?page=news&type=view&id=publications%2Fgenotoxic-stress-and&filter=22
A vital enzyme holds key to the fight against cancer and viral infections
- 1,361 views
- Added
Edited
Latest News
Metabolic rewiring promotes…
By newseditor
Posted 18 Apr
A drug to prevent flu-induc…
By newseditor
Posted 18 Apr
New origin of deep brain waves
By newseditor
Posted 17 Apr
Starving cells hijack prote…
By newseditor
Posted 17 Apr
Miniature battery-free epid…
By newseditor
Posted 17 Apr
Other Top Stories
Why alcohol, sugar lead to thirst
Read more
Why is it harder for females to gain weight?
Read more
Enduring cold temperatures alters fat cell epigenetics
Read more
Diabetes compound more effective by altering receptor trafficking
Read more
Pediatric obesity, depression connected in the brain
Read more
Protocols
MemPrep, a new technology f…
By newseditor
Posted 08 Apr
A tangible method to assess…
By newseditor
Posted 08 Apr
Stem cell-derived vessels-o…
By newseditor
Posted 06 Apr
Single-cell biclustering fo…
By newseditor
Posted 01 Apr
Modular dual-color BiAD sen…
By newseditor
Posted 31 Mar
Publications
How does the microbiota con…
By newseditor
Posted 18 Apr
The integrated stress respo…
By newseditor
Posted 18 Apr
The immunobiology of herpes…
By newseditor
Posted 17 Apr
Circulating microbiome DNA…
By newseditor
Posted 17 Apr
Spindle oscillations in com…
By newseditor
Posted 17 Apr
Presentations
Hydrogels in Drug Delivery
By newseditor
Posted 12 Apr
Lipids
By newseditor
Posted 31 Dec
Cell biology of carbohydrat…
By newseditor
Posted 29 Nov
RNA interference (RNAi)
By newseditor
Posted 23 Oct
RNA structure and functions
By newseditor
Posted 19 Oct
Posters
A chemical biology/modular…
By newseditor
Posted 22 Aug
Single-molecule covalent ma…
By newseditor
Posted 04 Jul
ASCO-2020-HEALTH SERVICES R…
By newseditor
Posted 23 Mar
ASCO-2020-HEAD AND NECK CANCER
By newseditor
Posted 23 Mar
ASCO-2020-GENITOURINARY CAN…
By newseditor
Posted 23 Mar